Source:http://linkedlifedata.com/resource/pubmed/id/21338577
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-5-9
|
pubmed:abstractText |
Cancer/Testis (CT) antigens are considered promising target molecules for immunotherapy. To identify potential CT antigens, we performed immunoscreening of a testis cDNA library with sera from colon cancer patients by SEREX. We isolated 114 positive cDNA clones comprising 90 different antigens, designated BCP-1 through BCP-90. Quantitative real-time and conventional RT-PCR analysis showed that BCP-20, -33, and -41 antigens were expressed strongly only in a normal testis and detected in 22 cases (39%), 12 cases (21%), and 17 cases (30%), respectively, from 57 colon tumors. BCP-20 was also detected in various cancer cell lines including breast, colon, hepatoma, renal, thyroid anaplastic, ovary, sarcoma, and lung. By ELISA analysis, anti-BCP-20 antibody was detected in 3 of 50 colon cancer and 1 of 24 gastric cancer patients while healthy donors were three positive (3/50). But the BCP-20 antibody levels of patients with colon cancer showed significantly higher titers than those of healthy donors. These data suggest that the BCP-20 gene is a new CT antigen and may be useful for diagnosis and immunotherapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1090-2104
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
6
|
pubmed:volume |
408
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195-201
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21338577-Aged,
pubmed-meshheading:21338577-Aged, 80 and over,
pubmed-meshheading:21338577-Antigens, Neoplasm,
pubmed-meshheading:21338577-Colonic Neoplasms,
pubmed-meshheading:21338577-DNA, Recombinant,
pubmed-meshheading:21338577-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21338577-F-Box Proteins,
pubmed-meshheading:21338577-Female,
pubmed-meshheading:21338577-Gene Library,
pubmed-meshheading:21338577-Humans,
pubmed-meshheading:21338577-Immunotherapy,
pubmed-meshheading:21338577-Male,
pubmed-meshheading:21338577-Middle Aged,
pubmed-meshheading:21338577-Neoplasm Proteins,
pubmed-meshheading:21338577-Polymerase Chain Reaction,
pubmed-meshheading:21338577-Serologic Tests,
pubmed-meshheading:21338577-Testis
|
pubmed:year |
2011
|
pubmed:articleTitle |
Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX.
|
pubmed:affiliation |
Department of Biochemistry, School of Medicine, Pusan National University, Beomeo-ri, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do 626-770, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|